The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $36 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $36 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
Home » For Patients » Living with NETs » Carcinoid Syndrome » Carcinoid Syndrome Diagnosis
Carcinoid syndrome is a constellation, collection, or group of symptoms experienced by a subset of people who have a neuroendocrine tumor.
The diagnosis of carcinoid syndrome is complicated by the fact that common conditions, such as irritable bowel syndrome and severe allergic reactions, can cause symptoms similar to those of carcinoid syndrome.
To make a carcinoid syndrome diagnosis, a doctor will likely begin by assessing your symptoms and ruling out or excluding other conditions with similar presentations. The process of considering other conditions that may be responsible for your symptoms is called a “differential diagnosis.”
If you have not been diagnosed with a neuroendocrine tumor, initial tests involve screening for biochemical markers of neuroendocrine tumors, followed by attempts to localize the tumor by using imaging (MRI, CT, scintigraphy) and/or endoscopic tests.1
If you have been diagnosed with a neuroendocrine tumor, testing will try to learn about any changes that may be going on with the tumor.
Read about testing for carcinoid syndrome.
NETRF awarded six new research grants totaling $1.85 million to leading academic institutions around the world. The goal of the funding is to improve current treatments for neuroendocrine tumors (NETs), an uncommon and poorly understood cancer, which occurs in the body’s hormone-producing cells.
Detecting and Monitoring NETs: Listen as NETWise takes you on a journey to diagnose neuroendocrine cancer.
NETRF awarded six new research grants totaling $1.85 million to leading academic institutions around the world. The goal of the funding is to improve current treatments for neuroendocrine tumors (NETs), an uncommon and poorly understood cancer, which occurs in the body’s hormone-producing cells.
Functional and Non-Functional NETs This episode is about managing the symptoms of functional NETs. To